EFIC
GILD icon

Eliot Finkel Investment Counsel’s Gilead Sciences GILD Stock Holding History

Eliot Finkel Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-44,470
Closed -$3.15M – 36
2017
Q2 		$3.15M Hold
44,470
– – 2.31% 26
2017
Q1 		$3.02M Buy
44,470
+1,000
+2% +$70.3K 2.32% 25
2016
Q4 		$3.11M Sell
43,470
-6,405
-13% -$476K 2.64% 21
2016
Q3 		$3.95M Buy
49,875
+10,645
+27% +$865K 3.55% 16
2016
Q2 		$3.27M Buy
39,230
+18,920
+93% +$1.68M 2.92% 19
2016
Q1 		$1.87M Buy
20,310
+13,470
+197% +$1.21M 1.7% 26
2015
Q4 		$692K Buy
+6,840
New +$712K 0.67% 32

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eliot Finkel Investment Counsel's GILD Position: Q3 2017 in Review

Eliot Finkel Investment Counsel sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 44,470 shares — an estimated $3.15M sold.

Eliot Finkel Investment Counsel first reported a position in GILD in Q4 2015 and held it in 7 quarters. The position peaked at $3.95M in Q3 2016. 1,504 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

  • Eliot Finkel Investment Counsel reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
  • Eliot Finkel Investment Counsel sold 44,470 Gilead Sciences shares in Q3 2017, an estimated $3.15M.
  • Eliot Finkel Investment Counsel first reported a position in Gilead Sciences in Q4 2015 and held it in 7 quarters.
  • Eliot Finkel Investment Counsel's Gilead Sciences position peaked at $3.95M in Q3 2016.
  • 1,504 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on Eliot Finkel Investment Counsel's 13F filing for Q3 2017, filed 8 Nov 2017.